Tevogen Bio Holdings appoints KPMG as auditor, dismisses Marcum

Tevogen Bio Holdings Inc.

Audit committee appointed KPMG as independent auditor for FY2024, effective immediately.
Marcum dismissed as auditor; its prior reports contained a going-concern explanatory paragraph.
Company disclosed a material weakness in internal controls over complex financial instruments and related-party collectability.
No disagreements or reportable events with Marcum; Marcum provided a letter agreeing with disclosures.
KPMG had served as auditor for Tevogen Bio Inc. prior to the June 2023 business combination.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Tevogen Bio Holdings Inc. engaged KPMG LLP as its auditor.

Action: engagement
Auditor: KPMG LLP

Exact text from the filing

Appointment of Independent Registered Public Accounting Firm On April 29, 2024, the audit committee of the Board of Directors (the “Audit Committee”) of Tevogen Bio Holdings Inc. (the “Company”) approved the appointment of KPMG LLP (“KPMG”) as the Company’s new independent registered public accounting firm for

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Tevogen Bio Holdings Inc. dismissed Marcum LLP as its auditor.

Action: dismissal
Auditor: Marcum LLP
Successor: KPMG LLP

Exact text from the filing

the Audit Committee dismissed Marcum as the Company's independent registered public accounting firm.

View on SEC.gov

47 auditor changes filed in the last 30 days. Browse all auditor changes →

Tevogen Bio Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-017597

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.